Source comparison
Dosing Protocols, Bioavailability, and Comparison with Related Immune Peptides
Standard thymosin alpha-1 research review protocols employ subcutaneous injection at doses ranging from 0.8mg to 3.2mg, administered 1–3 times weekly depending on indication. The peptide's half-life is approximately 2 hours in circulation, but biological effec
This comparison does not assign a generated winner or score.
- Standard thymosin alpha-1 research review protocols employ subcutaneous injection at doses ranging from 0.8mg to 3.2mg, administered 1–3 times weekly depending on indication. The peptide's half-life is approximately 2 hours in circulation, but biological effects persist 48–72 hours due to sustained changes in receptor expression and cell activation states. Peak serum concentration occurs 60–90 minutes post-injection, with bioavailability near 100% via subcutaneous route. Oral administration is ineffective due to proteolytic degradation in the GI tract.
- Dose-response curves show a plateau effect. Research published in International Immunopharmacology found that doses above 1.6mg twice weekly provided minimal additional IL-2 receptor upregulation compared to 1.6mg, suggesting receptor saturation kinetics. For acute infectious indications (severe COVID-19, acute hepatitis), higher-frequency protocols (daily or twice-daily 1.6mg) were employed; for chronic conditions (hepatitis B, melanoma adjuvant), 1.6mg twice weekly for 12–24 weeks is standard.
- Compared to related immune peptides, Tα1 occupies a specific niche. Thymalin, a thymic extract containing multiple bioactive peptides, produces broader but less defined immunomodulation. LL 37, an antimicrobial peptide, works through direct pathogen membrane disruption rather than adaptive immune modulation. KPV 5MG targets inflammatory pathways via melanocortin receptor activation, a distinct mechanism from Tα1's T-cell focus. The choice between peptides depends on whether the research goal is T-cell-mediated immunity (Tα1), innate immune activation (LL-37), or anti-inflammatory signaling (KPV).
- Reconstitution requires bacteriostatic water at 1:1 or 2:1 ratios depending on supplied concentration. Once reconstituted, solutions remain stable for 28 days refrigerated at 2–8°C. Lyophilized powder stored at −20°C retains potency for 24+ months. Temperature excursions above 25°C for extended periods (>72 hours) risk peptide degradation. A concern we address through cold-chain shipping for all research-grade peptides in our catalog at Real Peptides.